RxDoctor Payments Data

Gary Pinta, MD

Internal Medicine · Cuyahoga Falls, OHNPI 1023008752

Payments from drug & device makers

$14,096in general payments, 2019–2025

Across 946 payments — averaging $14.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$2K
  • Pfizer$1K
  • GSK$1K
  • Lilly USA, LLC$802
  • Astellas Pharma US Inc$742
  • plus $6K from 46 others

What the payments were for

  • Food & beverage$13,84898%
  • Education$2482%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$14,096 in reported general payments places this provider in the 95th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$151,079
Medicare patients
224
Services billed
2,168

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban149$171,714
JanuviaSitagliptin Phosphate69$92,479
OzempicSemaglutide87$87,863
JardianceEmpagliflozin97$82,373
Trelegy ElliptaFluticasone/Umeclidin/Vilanter52$54,985
FarxigaDapagliflozin Propanediol49$48,932
MyrbetriqMirabegron40$29,044
Breo ElliptaFluticasone/Vilanterol37$28,882
XareltoRivaroxaban18$28,875
EntrestoSacubitril/Valsartan13$19,516
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr25$18,864
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$14,802
MounjaroTirzepatide14$14,571
Fluticasone-SalmeterolFluticasone Propion/Salmeterol58$11,172
LinzessLinaclotide11$10,972

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$1,247$174,598181 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$1,198$102,731114 claims
MerckJanuvia, Belsomra$514$97,39980 claims
Novo NordiskOzempic$1,624$87,86387 claims
Boehringer IngelheimJardiance$412$82,37397 claims
AstraZenecaFarxiga, Breztri Aerosphere$738$63,73467 claims
Astellas Pharma US IncMyrbetriq$742$29,04440 claims
Johnson & JohnsonXarelto$141$28,87518 claims
NovartisEntresto$228$19,51613 claims
Lilly USA, LLCMounjaro$802$14,57114 claims
AbbVieLinzess$2,366$10,97211 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$42$4,599382 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Cuyahoga Falls

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →